One-carbon Therapeutics - Crunchbase Company Profile & Funding

Q: How much funding has One-carbon Therapeutics raised to date?

One-carbon Therapeutics has raised obfuscated.

Overview

One-carbon Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About One-carbon Therapeutics

CB Rank

60169

One-carbon Therapeutics offers scientific solutions for treatment against MTHFD1/2 cancer proteins and related targets.

Founded

obfuscation

Private

Funding Round

Stockholm, Stockholms Lan, Sweden

11-50

one-carbon.com

Biotechnology

Health Care

Medical

Funding Rounds

Funding Round

OBF

obfuscation

Details

Legal Name

One-carbon therapeutics AB

Operating Status

Active

Company Type

For Profit

Phone Number

+467 08822115

Predictions & Insights

Growth Insight

See this Growth Insight

One-carbon Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

MTHFD1/2 Inhibitor TH9619

A small molecule inhibitor targeting MTHFD1 and MTHFD2 enzymes to induce replication stress and cancer cell death by disrupting one-carbon metabolism pathways.

ODIN Clinical Phase 1/2 Trial

A clinical trial evaluating the safety and efficacy of One-carbon Therapeutics' drug candidates targeting MTHFD1/2 in cancer patients across Europe.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Funding Round - One-carbon Therapeutics	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - One-carbon Therapeutics	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - One-carbon Therapeutics	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - One-carbon Therapeutics	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - One-carbon Therapeutics	—	obfuscated obfuscation	—	Funding Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Funding Round - One-carbon Therapeutics	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - One-carbon Therapeutics	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - One-carbon Therapeutics	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - One-carbon Therapeutics	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - One-carbon Therapeutics	—	obfuscated obfuscation	—	Funding Round